[go: up one dir, main page]

BERGSTROM, 1978 - Google Patents

Hypercalciuria and hypercalcemia complicating immobilization

BERGSTROM, 1978

Document ID
8767836762777935866
Author
BERGSTROM W
Publication year
Publication venue
American Journal of Diseases of Children

External Links

Snippet

In this issue of theJournal (132: 560-564, 1978), Rosen and his colleagues reemphasize a phenomenon long known but often forgotten, the dissolution of bone that results from immoblization. They described six boys, between 4 and 16 years old, in whom …
Continue reading at jamanetwork.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/0193—Apparatus specially adapted for treating hip dislocation; Abduction splints

Similar Documents

Publication Publication Date Title
Hulley et al. The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest
Jowsey et al. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis
Kaplan et al. Reduction of hypercalciuria in tetraplegia after weight-bearing and strengthening exercises
ES2330111T3 (en) COMPOSITION AND METHOD TO FACILITATE BONE HEALING.
Baylink et al. Systemic factors in alveolar bone loss
BERGSTROM Hypercalciuria and hypercalcemia complicating immobilization
AU625809B2 (en) Novel calcium supplements
Steinberg The immobilized patient: functional pathology and management
Salvesen et al. Idiopathic hypoparathyroidism
Wyse et al. Effect of the oscillating bed and tilt table on calcium, phosphorus and nitrogen metabolism in paraplegia
HWANG et al. Effect of prolonged bedrest on the propensity for renal stone formation
US5314919A (en) Calcium supplements
CA1329774C (en) Methods for the treatment of osteoporosis and related disorders
Harmon Parathyroid adenoma in a child: report of a case presenting as central nervous system disease and complicated by magnesium deficiency
Wasserman et al. Osteoporosis: the state of the art in 1987: a review
Van den Brink et al. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.
Asling et al. Anterior pituitary regulation of skeletal development
Rico et al. Longitudinal study of the effect of calcium pidolate on bone mass in eugonadal women
Mallette Acetazolamide-accelerated anticonvulsant osteomalacia
US4185108A (en) Antiosteoporotic agents
US4125621A (en) Antiosteoporotic agents
Kesson et al. Generalized osteoporosis in old age
Ahl et al. Bone mineral content in the calcaneus after ankle fracture
Allen et al. Hypo-hyperparathyroidism
Griffet et al. Duplication of the leg—renal agenesis: congenital malformation syndrome